PGxAI

PGxAI is a GenAI-driven precision-medicine platform that continuously learns from real-world evidence (RWE) to individualize drug therapy for every patient.

• Multi-omics intelligence. Beyond pharmacogenomics, the engine integrates proteomic, transcriptomic, and metabolomic biomarkers to predict efficacy, dosage, and adverse-event risk with unparalleled granularity.

• InterSystems native. Built on InterSystems IRIS for Health and FHIR-native TrakCare standards, PGxAI ingests longitudinal data directly from EHRs, LIMS, and wearable devices with minimal integration overhead.

• Federated learning at scale. HealthShare Health Connect enables privacy-preserving aggregation of therapeutic outcomes from multiple organizations worldwide, allowing the model to retrain daily on tens of thousands of new cases.

• Actionable insights at the point of care. Clinicians receive guideline-grade recommendations—dosage adjustments, alternative medications, and monitoring plans—embedded in existing workflows, boosting safety, efficacy, and patient satisfaction.

By unifying global outcome data with rich omics profiles, PGxAI delivers a continuously improving, population-aware decision-support layer that turns routine clinical data into personalized treatment plans—ushering in the next era of precision medicine.